VWA5B1

gene
On this page

Also known as FLJ32784

Summary

VWA5B1 (von Willebrand factor A domain containing 5B1, HGNC:26538) is a protein-coding gene on chromosome 1p36.12, encoding von Willebrand factor A domain-containing protein 5B1 (Q5TIE3).

Predicted to be located in extracellular region.

Source: NCBI Gene 127731 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 269 total
  • MANE Select transcript: NM_001039500

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26538
Approved symbolVWA5B1
Namevon Willebrand factor A domain containing 5B1
Location1p36.12
Locus typegene with protein product
StatusApproved
AliasesFLJ32784
Ensembl geneENSG00000158816
Ensembl biotypeprotein_coding
Entrez127731

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 6 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000289815, ENST00000375079, ENST00000467486, ENST00000473325, ENST00000485375, ENST00000525343, ENST00000530722, ENST00000534075, ENST00000893215, ENST00000919186

RefSeq mRNA: 2 — MANE Select: NM_001039500 NM_001039500, NM_001377531

Canonical transcript exons

ENST00000289815 — 22 exons

ExonStartEnd
ENSE000014657172035375720359518
ENSE000034599032034307920343393
ENSE000034681522034243220342609
ENSE000034690442031283620312988
ENSE000034816612033086920330983
ENSE000034902402031432220314592
ENSE000035266612032335620323532
ENSE000035354922031753020317675
ENSE000035381062033630320336486
ENSE000035406972031859020318721
ENSE000035446182035015620350230
ENSE000035550402035085720350926
ENSE000035563252034545620345593
ENSE000035784632031057620310740
ENSE000035992612033276620332951
ENSE000036194382033764620337836
ENSE000036232422034824520348358
ENSE000036281002032789020328000
ENSE000036536092031938220319506
ENSE000036706312033018020330382
ENSE000036930962035205520352172
ENSE000039214652029087520291088

Expression profiles

Bgee: expression breadth broad, 90 present calls, max score 72.39.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0550 / max 12.9796, expressed in 25 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
11180.055025

Top tissues by expression

219 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pituitary glandUBERON:000000772.39gold quality
adenohypophysisUBERON:000219672.05gold quality
left testisUBERON:000453371.36gold quality
right testisUBERON:000453470.33gold quality
testisUBERON:000047368.96gold quality
right uterine tubeUBERON:000130268.36gold quality
ventricular zoneUBERON:000305364.32gold quality
hypothalamusUBERON:000189863.55gold quality
metanephros cortexUBERON:001053361.47gold quality
adult mammalian kidneyUBERON:000008260.40gold quality
ganglionic eminenceUBERON:000402359.50gold quality
metanephrosUBERON:000008155.21gold quality
kidneyUBERON:000211354.51gold quality
gall bladderUBERON:000211053.51gold quality
germinal epithelium of ovaryUBERON:000130453.10gold quality
cortex of kidneyUBERON:000122552.90gold quality
urinary bladderUBERON:000125550.25gold quality
gingival epitheliumUBERON:000194950.10gold quality
buccal mucosa cellCL:000233649.58gold quality
islet of LangerhansUBERON:000000649.46gold quality
middle temporal gyrusUBERON:000277149.43gold quality
tonsilUBERON:000237248.41silver quality
amygdalaUBERON:000187647.89gold quality
caudate nucleusUBERON:000187347.80gold quality
gingivaUBERON:000182846.96gold quality
fallopian tubeUBERON:000388946.40gold quality
Brodmann (1909) area 23UBERON:001355446.22gold quality
upper leg skinUBERON:000426246.12silver quality
forebrainUBERON:000189045.81gold quality
Ammon’s hornUBERON:000195445.74gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-119yes39.42
E-ANND-3yes5.23

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

31 targeting VWA5B1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4481100.0066.421669
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-311999.9271.342390
HSA-MIR-130B-5P99.8368.501888
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-18A-3P99.5665.681092
HSA-MIR-4687-3P99.4866.41968
HSA-MIR-317699.2564.35954
HSA-MIR-3922-3P99.2564.961136
HSA-MIR-4685-5P99.2565.991563
HSA-MIR-6837-5P99.2565.471632
HSA-MIR-628-3P99.0468.37814
HSA-MIR-7153-3P99.0065.35608
HSA-MIR-6770-5P98.9766.761853
HSA-MIR-455-5P98.7467.31795
HSA-MIR-5011-3P98.6364.81638
HSA-MIR-5089-5P98.4566.061388
HSA-MIR-5008-5P98.4265.871019
HSA-MIR-6842-3P98.0766.331325
HSA-MIR-365297.7165.431890
HSA-MIR-443097.4765.611813
HSA-MIR-6736-3P96.9865.221342
HSA-MIR-212-5P96.8367.43950
HSA-MIR-550B-2-5P96.5664.61646
HSA-MIR-465495.8665.72751
HSA-MIR-425995.6865.25582
HSA-MIR-4769-5P95.3766.09570

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriovwa5b1ENSDARG00000059705
mus_musculusVwa5b1ENSMUSG00000028753
rattus_norvegicusVwa5b1ENSRNOG00000016553

Paralogs (11): ITIH4 (ENSG00000055955), ITIH1 (ENSG00000055957), ITIH6 (ENSG00000102313), PARP4 (ENSG00000102699), VWA5A (ENSG00000110002), ITIH5 (ENSG00000123243), VWA5B2 (ENSG00000145198), ITIH2 (ENSG00000151655), ITIH3 (ENSG00000162267), VWA3B (ENSG00000168658), VWA3A (ENSG00000175267)

Protein

Protein identifiers

von Willebrand factor A domain-containing protein 5B1Q5TIE3 (reviewed: Q5TIE3)

All UniProt accessions (6): E9PMB3, E9PNX8, E9PP07, E9PQ62, Q5TIE3, H0YED8

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

Isoforms (5)

UniProt IDNamesCanonical?
Q5TIE3-11yes
Q5TIE3-22
Q5TIE3-33
Q5TIE3-44
Q5TIE3-55

RefSeq proteins (2): NP_001034589, NP_001364460 (=MANE)

Domains & families (InterPro)

IDNameType
IPR002035VWF_ADomain
IPR013694VITDomain
IPR036465vWFA_dom_sfHomologous_superfamily
IPR052627VWA_domain-containingFamily

Pfam: PF13757, PF13768

UniProt features (30 total): splice variant 8, sequence variant 4, region of interest 4, compositionally biased region 3, glycosylation site 3, sequence conflict 3, domain 2, signal peptide 1, chain 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5TIE3-F166.500.38

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 881

Glycosylation sites (3): 140, 650, 1017

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 19 (showing top): HAND1E47_01, TAL1BETAE47_01, chr1p36, NABA_ECM_GLYCOPROTEINS, MIR3922_3P, MIR3176, DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS, DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP, GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN, OLF1_01, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN, NABA_CORE_MATRISOME, NABA_MATRISOME

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

564 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
VWA5B1KIAA2012Q0VF49666
VWA5B1VSTM5A8MXK1542
VWA5B1XKR5Q6UX68507
VWA5B1TATDN2Q93075483
VWA5B1ARL5CA6NH57482
VWA5B1DUSP21Q9H596433
VWA5B1TMEM87BQ96K49379
VWA5B1ZPLD1Q8TCW7366
VWA5B1MFAP1P55081324
VWA5B1CLBA1Q96F83323
VWA5B1SKIC3Q6PGP7311
VWA5B1COL26A1Q96A83303
VWA5B1LRWD1Q9UFC0302
VWA5B1TICRRQ7Z2Z1299
VWA5B1HIVEP3Q5T1R4295

IntAct

2 interactions, top by confidence:

ABTypeScore
VWA5B1H2BC21psi-mi:“MI:0915”(physical association)0.400

BioGRID (1): VWA5B1 (Proximity Label-MS)

ESM2 similar proteins: A0A140LI67, A2AKB4, A6QLD5, A9Z1V5, C0HAC0, D4A7V9, O43187, O70173, O88866, P97573, Q08DV9, Q0P5I2, Q1L981, Q2YDQ5, Q3TYG6, Q3U3D7, Q4QQS0, Q5F479, Q5JV73, Q5R810, Q5SUS0, Q5SY16, Q5TIE3, Q5XX13, Q68DX3, Q6DIL6, Q6GQ34, Q6IRN0, Q6IRU7, Q6P1H6, Q6P4K6, Q6P4T1, Q80TI1, Q8BLA1, Q8BLQ0, Q8BW88, Q8C008, Q8CFA1, Q8QHJ9, Q8TC57

Diamond homologs: A9Z1V5, C7G046, O00534, Q3UR50, Q54CQ8, Q54DU5, Q54DV3, Q54MG1, Q54MG4, Q55G98, Q5TIE3, Q75WE7, Q8N398, A0A1S3C4H6, B9FXV5, G5CEW6, O43432, P41110, Q03387, Q04637, Q41583, Q6K641, Q6NZJ6, Q76E23, Q80XI3, Q84PB3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

269 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance247
Likely benign11
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

4397 predictions. Top by Δscore:

VariantEffectΔscore
1:20310739:GG:Gdonor_gain1.0000
1:20310740:GG:Gdonor_gain1.0000
1:20310740:GGT:Gdonor_loss1.0000
1:20310741:GTAAG:Gdonor_loss1.0000
1:20310742:T:Adonor_loss1.0000
1:20312987:AGG:Adonor_loss1.0000
1:20312988:GGTAA:Gdonor_loss1.0000
1:20312989:GT:Gdonor_loss1.0000
1:20312990:T:Gdonor_loss1.0000
1:20314370:C:Aacceptor_gain1.0000
1:20318580:T:Gacceptor_gain1.0000
1:20318719:GCG:Gdonor_gain1.0000
1:20318722:G:GGdonor_gain1.0000
1:20330341:G:Tdonor_gain1.0000
1:20330342:A:Tdonor_gain1.0000
1:20332947:GATCT:Gdonor_gain1.0000
1:20332952:G:GGdonor_gain1.0000
1:20336300:CAG:Cacceptor_loss1.0000
1:20336301:A:ACacceptor_loss1.0000
1:20336301:AG:Aacceptor_gain1.0000
1:20336302:GG:Gacceptor_gain1.0000
1:20336302:GGACA:Gacceptor_gain1.0000
1:20336482:GCACG:Gdonor_gain1.0000
1:20343078:GAGCC:Gacceptor_gain1.0000
1:20343389:GCAGG:Gdonor_gain1.0000
1:20343392:GG:Gdonor_gain1.0000
1:20343393:GG:Gdonor_gain1.0000
1:20345452:A:AGacceptor_gain1.0000
1:20345452:ACAG:Aacceptor_gain1.0000
1:20345452:ACAGG:Aacceptor_gain1.0000

AlphaMissense

7951 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:20318598:A:CS240R0.998
1:20318600:T:AS240R0.998
1:20318600:T:GS240R0.998
1:20332823:T:AW544R0.996
1:20332823:T:CW544R0.996
1:20312886:G:CA64P0.994
1:20345494:A:CS889R0.994
1:20345496:C:AS889R0.994
1:20345496:C:GS889R0.994
1:20354033:T:AW1145R0.993
1:20354033:T:CW1145R0.993
1:20345515:A:CS896R0.992
1:20345517:C:AS896R0.992
1:20345517:C:GS896R0.992
1:20354093:T:AW1165R0.992
1:20354093:T:CW1165R0.992
1:20310705:T:CL35P0.991
1:20317646:T:CL227P0.990
1:20312881:T:CF62S0.989
1:20354114:G:CA1172P0.989
1:20318617:G:CR246P0.988
1:20312880:T:CF62L0.986
1:20312882:T:AF62L0.986
1:20312882:T:GF62L0.986
1:20354035:G:CW1145C0.986
1:20354035:G:TW1145C0.986
1:20310612:T:CL4S0.985
1:20343208:T:AV814D0.985
1:20354095:G:CW1165C0.985
1:20354095:G:TW1165C0.985

dbSNP variants (sampled 300 via entrez): RS1000027948 (1:20344085 C>G,T), RS1000084957 (1:20313953 A>G), RS1000119951 (1:20337896 T>C), RS1000173985 (1:20350259 A>C,G), RS1000203878 (1:20311823 C>A,T), RS1000231277 (1:20307189 C>T), RS1000257968 (1:20350102 G>A), RS1000262344 (1:20306972 T>C), RS1000375733 (1:20355546 C>A,G), RS1000385097 (1:20316517 A>G), RS1000514884 (1:20326778 A>G), RS1000525692 (1:20301918 G>A), RS1000560273 (1:20331159 T>G), RS1000560530 (1:20305851 G>A,T), RS1000588732 (1:20349673 T>TGCC)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST004685_1Psychosis proneness (perceptual aberration scale)4.000000e-06
GCST007478_1Non-word reading6.000000e-06
GCST010002_378Refractive error1.000000e-09
GCST010118_1Type 2 diabetes4.000000e-10

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008337psychosis predisposition measurement
EFO:0005299non-word reading

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
fluorene-9-bisphenoldecreases expression1
bisphenol Aaffects cotreatment, decreases methylation1
benzo(e)pyreneincreases methylation1
Grape Seed Proanthocyanidinsaffects cotreatment, decreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Aldehydesincreases expression1
Benzo(a)pyreneaffects methylation1
Catechinaffects cotreatment, decreases expression1
Methapyrileneincreases methylation1
Vanadiumincreases abundance, increases methylation1
Metals, Heavyincreases abundance, increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.